Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

The treatment combination is effective and generally safe for lung cancer.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

FOLFOX6 chemotherapy effectively reduces VEGF levels and improves quality of life in advanced colorectal cancer patients.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

The new drug delivery system effectively targets lung cancer cells.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Anti-CD19 therapy may help treat SLE and NMOSD.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

A woman with severe angioedema improved significantly after treatment with rituximab.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Targeting ornithine decarboxylase can help prevent skin cancer.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

ONCO-NK-TRANSITION-GM1 is a low-cost, effective cancer treatment with a high cure rate and no severe side effects.

ONCO-NK-TRANSITION-GM1 is a low-cost, effective cancer treatment with a high cure rate and no severe side effects.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Blocking the Hedgehog pathway may help overcome drug resistance in multiple myeloma.